DMK PHARMACEUTICALS Corp Quarterly Debt-to-equity in % from Q2 2017 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
DMK PHARMACEUTICALS Corp quarterly Debt-to-equity history and growth rate from Q2 2017 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Debt-to-equity for the quarter ending September 30, 2023 was -219 %, a 341% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -219 -309 -341% Sep 30, 2023
Q2 2023 -285 -343 -592% Jun 30, 2023
Q1 2023 -8.3K -8.34K -18750% Mar 31, 2023
Q4 2022 184 +144 +356% Dec 31, 2022
Q3 2022 90.7 +34.1 +60.4% Sep 30, 2022
Q2 2022 58 -14.7 -20.2% Jun 30, 2022
Q1 2022 44.5 -49.8 -52.8% Mar 31, 2022
Q4 2021 40.4 -68.1 -62.8% Dec 31, 2021
Q3 2021 56.5 -12 -17.6% Sep 30, 2021
Q2 2021 72.7 +23.8 +48.6% Jun 30, 2021
Q1 2021 94.3 +54.8 +139% Mar 31, 2021
Q4 2020 108 +72 +198% Dec 31, 2020
Q3 2020 68.6 +37.2 +119% Sep 30, 2020
Q2 2020 48.9 +20.7 +73.5% Jun 30, 2020
Q1 2020 39.5 +9.49 +31.6% Mar 31, 2020
Q4 2019 36.5 +6.85 +23.1% Dec 31, 2019
Q3 2019 31.4 +0.29 +0.93% Sep 30, 2019
Q2 2019 28.2 -3.94 -12.3% Jun 30, 2019
Q1 2019 30 +2.14 +7.68% Mar 31, 2019
Q4 2018 29.6 -2.52 -7.84% Dec 31, 2018
Q3 2018 31.1 -5.2 -14.3% Sep 30, 2018
Q2 2018 32.1 -13.1 -29% Jun 30, 2018
Q1 2018 27.9 Mar 31, 2018
Q4 2017 32.1 Dec 31, 2017
Q3 2017 36.3 Sep 30, 2017
Q2 2017 45.3 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.